相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene
Ge Peng et al.
INFLAMMATION (2018)
IL-33 promotes gastrointestinal allergy in a TSLP-independent manner
H. Han et al.
MUCOSAL IMMUNOLOGY (2018)
Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview
M. Hassani et al.
ALLERGY (2018)
Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois
Noriko Ogasawara et al.
ALLERGY (2018)
Human eosinophils and mast cells: Birds of a feather flock together
Piper A. Y. Robida et al.
IMMUNOLOGICAL REVIEWS (2018)
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
Kenji Kabashima et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
IL-31: A new key player in dermatology and beyond
Isin Sinem Bagci et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids
Philip Korenblat et al.
RESPIRATORY MEDICINE (2018)
Airway Inflammation and Inflammatory Biomarkers
Hui Fang Lim et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
J. M. Orengo et al.
NATURE COMMUNICATIONS (2018)
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells
Jiayun Hu et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2018)
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies
Sathyadevi Venkataramani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid
Alex Kaye et al.
JAMA DERMATOLOGY (2018)
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
Hiroki Kabata et al.
IMMUNOLOGICAL REVIEWS (2018)
Non-eosinophilic asthma: current perspectives
Ignacio Esteban-Gorgojo et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy
L. F. Larsen et al.
ALLERGY (2018)
Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
M. Furue et al.
ALLERGY (2018)
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
S. Broesby-Olsen et al.
ALLERGY (2018)
High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers
T. Boonpiyathad et al.
ALLERGY (2017)
Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis
Iris M. Otani et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Lifelong memory responses perpetuate humoral TH2 immunity and anaphylaxis in food allergy
Rodrigo Jimenez-Saiz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tezepelumab in Adults with Uncontrolled Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders
Erik Wambre et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Anti-Interleukin-9 Antibody Increases the Effect of Allergen-Specific Immunotherapy in Murine Allergic Rhinitis
Ji-Hyeon Shin et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2017)
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
Geoffrey L. Chupp et al.
LANCET RESPIRATORY MEDICINE (2017)
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
Kevin Murphy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5
Tsutomu Yanagibashi et al.
CYTOKINE (2017)
Omalizumab effectively protects against early and late allergic responses in asthma after 4 weeks
J. Trischler et al.
ALLERGY (2017)
The role of regulatory B cells in allergen immunotherapy
Willem van de Veen
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
M. H. Shamji et al.
ALLERGY (2017)
Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology
A. Muraro et al.
ALLERGY (2017)
Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps
Mingyu Lee et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)
The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies
Mitchell Goldman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
Andrew C. Nyborg et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
Jakob von Moltke et al.
NATURE (2016)
Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study
Eric Sheldon et al.
ADVANCES IN THERAPY (2016)
The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response
Rob C. Aalberse et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Antonella Muraro et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Role of IgG4 in IgE-mediated allergic responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
Mubeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Human B-cell isotype switching origins of IgE
Timothy J. Looney et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Role of regulatory B cells in immune tolerance to allergens and beyond
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen- induced early asthmatic responses
Gail M. Gauvreau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
Marek Jutel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Successful immunotherapy induces previously unidentified allergen-specific CD4+T-cell subsets
John F. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis
Kevin M. Vannella et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Hector G. Ortega et al.
LANCET RESPIRATORY MEDICINE (2016)
Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma
Jeffrey M. Harris et al.
RESPIRATORY RESEARCH (2016)
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
O. Boyman et al.
ALLERGY (2015)
Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation
Rohit Divekar et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Ari B. Molofsky et al.
IMMUNITY (2015)
Drug evaluation review: dupilumab in atopic dermatitis
Jennifer D. Hamilton et al.
IMMUNOTHERAPY (2015)
T(H)9 cells are required for tissue mast cell accumulation during allergic inflammation
Sarita Sehra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
Hyun-Woo Shin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge
T. Hawro et al.
ALLERGY (2014)
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
J. P. Arm et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy
Helen A. Brough et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gail M. Gauvreau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
Bryony Stott et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization
Derek K. Chu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Type 2 innate lymphoid cells control eosinophil homeostasis
Jesse C. Nussbaum et al.
NATURE (2013)
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
Chad K. Oh et al.
RESPIRATORY RESEARCH (2013)
Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development
Marek Jutel et al.
ALLERGOLOGY INTERNATIONAL (2013)
The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells
Jenny Mjosberg et al.
IMMUNITY (2012)
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist
Rebecca E. Slager et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2
Natalija Novak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Sequential class switching is required for the generation of high affinity IgE antibodies
Huizhong Xiong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis
I. Spadoni et al.
MUCOSAL IMMUNOLOGY (2012)
The potential of biologics for the treatment of asthma
Girolamo Pelaia et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells
Phil-Dong Moon et al.
CYTOKINE (2011)
An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children With Eosinophilic Esophagitis
Amal H. Assa'ad et al.
GASTROENTEROLOGY (2011)
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Jan Lotvall et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils
Lars Blom et al.
PLOS ONE (2011)
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Jonathan Corren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
A. Straumann et al.
GUT (2010)
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice
Hans D. Brightbill et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness
Jian-Qing He et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Anti-CD20 (rituximab) treatment improves atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure
Flurina Meiler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The development of allergic inflammation
Stephen J. Galli et al.
NATURE (2008)
Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2008)
A mechanism for the initiation of allergen-induced T helper type 2 responses
Caroline L. Sokol et al.
NATURE IMMUNOLOGY (2008)
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma
Sarah J. Ballantyne et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
Miguel L. Stein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Omalizumab for asthma
RC Strunk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
IgE-mediated allergen presentation and blocking antibodies: Regulation of T-Cell activation in allergy
R. J. van Neerven et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients
T Nagato et al.
CLINICAL CANCER RESEARCH (2005)
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
T Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
BH Zhou et al.
NATURE IMMUNOLOGY (2005)
Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of TH2-attracting chemokines and disease severity
S Ying et al.
JOURNAL OF IMMUNOLOGY (2005)
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Cellular mechanisms of T cell mediated drug hypersensitivity
BO Gerber et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
M Akdis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP
V Soumelis et al.
NATURE IMMUNOLOGY (2002)
Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium
DR Wilson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)
H Milgrom et al.
PEDIATRICS (2001)
Human thymic stromal lymphopoietin preferentially stimulates myeloid cells
PA Reche et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
LC Borish et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: Role in IL-8 release
SG Abdelilah et al.
JOURNAL OF IMMUNOLOGY (2001)
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
MJ Leckie et al.
LANCET (2000)
Murine bone marrow-derived mast cells as potent producers of IL-9:: Costimulatory function of IL-10 and kit ligand in the presence of IL-1
M Stassen et al.
JOURNAL OF IMMUNOLOGY (2000)
IL-9 expression by human eosinophils: Regulation by IL-1 beta and TNF-alpha
AS Gounni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
分享论文
